Randomised crossover trial of a porous haemodialysis membrane compared to a conventional high-flux membrane in stable haemodialysis patients to determine the short term impact on inflammatory and nutritional indices.
Phase 4
Completed
- Conditions
- HaemodialysisEnd Stage Renal FailureRenal and Urogenital - Other renal and urogenital disorders
- Registration Number
- ACTRN12606000132549
- Lead Sponsor
- Fresenius
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Stable haemodialysis patients, currently dialysed with FX60 dialysers.
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method